Gedeon Richter

GEDEON RICHTER NEWSROOM (1 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2023 2020 2018 2014 2013

Gedeon Richter Plc. and Forest Laboratories, Inc. announce positive Phase IIb studies for cariprazine in both bipolar depression and major depressive disorder

PRESS RELEASE -- 1, April 2014

Budapest and New York, 1-4-2014 — /EuropaWire/ — Gedeon Richter Plc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive topline results from a Phase IIb trial evaluating the efficacy and safety of the investigational antipsychotic cariprazine in patients with bipolar depression. … Read the full press release